Overview Request Sample Pages Request Customization Download PDF
You are viewing: Japan Genomics Market analysis
Part of: Genomics Market (Global)

The Japan Genomics Market was valued at $1756.4 Million in 2025 and projected to reach to $2568 Million by 2030, representing a compound annual growth rate of CAGR 7.9%. Japan's genomics microarray market is poised for sustained growth driven by an aging population requiring advanced diagnostic solutions and increasing healthcare expenditure on precision medicine.

Japan Genomics Market Trends and Insights

  • Microarrays enable simultaneous analysis of thousands of genetic markers, making them essential for disease diagnosis, pharmacogenomics, and research applications.
  • The steady growth of Microarrays reflects increasing adoption in clinical laboratories and research institutions seeking cost-effective, high-throughput genomic solutions. Driving expansion through 2030, Microarrays benefit from declining sequencing costs, growing demand for personalized medicine, and established workflows in diagnostic settings.
  • Microarrays maintain competitive advantages in scalability and turnaround time compared to emerging alternatives.
  • The 7.9% CAGR for Microarrays underscores sustained market confidence, though Microarrays face competition from next-generation sequencing technologies.
  • Strategic investments in array design and automation continue to enhance Microarrays' clinical utility and market penetration across global healthcare systems..

Key Market Statistics

  • CAGR (2025-2030) CAGR 7.9%
  • Market Size, 2025 ~USD 1756.4 Million
  • Forecast, 2030 ~USD 2568 Million
  • Country Japan

Japan Genomics Market Overview

Market Size & Growth :

Japan's genomics microarray market is valued at USD 1,756.4 million in 2025, with a CAGR of 7.9% through 2030, reaching USD 2,568.0 million. This steady growth reflects Japan's advanced healthcare infrastructure and increasing genomic research investments.

Aging Population Demand :

Japan's rapidly aging demographic drives demand for genomic diagnostics and personalized medicine. Microarray technology supports early disease detection and pharmacogenomics applications critical for managing age-related conditions in the elderly population.

Research & Academic Leadership :

Japan's leading research institutions and universities are major adopters of microarray technology for genomic studies. Government funding initiatives and collaborations with pharmaceutical companies accelerate innovation in cancer genomics and rare disease research.

Regulatory & Healthcare Integration :

Japan's stringent regulatory environment and universal healthcare system create favorable conditions for genomic technology adoption. Integration of microarray diagnostics into clinical workflows is expanding across major hospitals and diagnostic centers nationwide.

Japan Genomics Market Dynamics

  • The country's strong research ecosystem and government support for genomic initiatives will continue to fuel adoption across academic and clinical settings.
  • Microarray technology remains essential for disease diagnosis, pharmacogenomics, and biomarker discovery in Japan's competitive healthcare landscape.
  • Market expansion will be supported by technological advancements, cost reductions, and growing integration into routine clinical diagnostics, positioning Japan as a key regional market for genomic innovations..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • Microarrays market grows from USD 1,756.4M (2025) to USD 2,568.0M (2030) at 7.9% CAGR
      • Microarrays remain cost-effective for high-throughput genomic analysis in clinical and research settings
      • Microarrays face competitive pressure from next-generation sequencing but maintain workflow advantages
      • Microarrays adoption accelerates through personalized medicine and diagnostic automation initiatives

      Genomics Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment SERVICES (Offering)
      Forecast Period 2025–2030
      Growth Rate CAGR of 12.6% from 2025 to 2030
      Largest Segment PRODUCTS (Offering)
      Market Size Base Year (Billions) ~USD 47.01 (2025)
      Revenue Forecast (Billions) ~USD 85.09 (2030)
      Segments Covered Offering, Type, Technology, End User, Study Type, Application

      Japan Genomics Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Offering

      • Products
      • Services

      By Type

      • Bioinformatics Services
      • Bioinformatics Tools
      • Cancer Diagnostics
      • Genomic Profiling & Sequencing Services
      • Infectious Disease Diagnostics
      • Instruments
      • Other Diagnostic Applications
      • Reagents, Kits, And Consumables
      • Reproductive Health Diagnostics
      • Sample Preparation & Library Preparation Services

      By Technology

      • Flow Cytometry
      • Gene Editing
      • In Situ Hybridization
      • Microarrays
      • Other Technologies
      • Pcr
      • Sequencing

      By End User

      • Academic & Research Institutes
      • Cros
      • Hospitals, Diagnostic Laboratories, And Clinics
      • Other End Users
      • Pharmaceutical & Biotechnology Companies

      By Study Type

      • Biomarker Discovery
      • Epigenomics
      • Functional Genomics
      • Other Study Types
      • Pathway Analysis

      By Application

      • Agriculture & Animal Research
      • Diagnostics
      • Drug Discovery & Development
      • Other Applications

      Target Audience

      • Genomics & Diagnostics Companies : Manufacturers and service providers of microarray platforms need Japan-specific market data to develop localized strategies, optimize product offerings, and identify growth opportunities in this mature healthcare market.
      • Healthcare Providers & Hospitals : Japanese hospitals and diagnostic centers require market insights to evaluate microarray technology investments, benchmark adoption rates, and align genomic services with patient demand and clinical guidelines.
      • Pharmaceutical & Biotech Firms : Pharma companies operating in Japan need genomics market intelligence to support pharmacogenomics research, clinical trial design, and precision medicine initiatives tailored to the Japanese population.
      • Investment & Private Equity Firms : Investors evaluating opportunities in Japan's healthcare sector require detailed market forecasts and competitive analysis to assess the viability and ROI potential of genomics-focused investments and acquisitions.
      • Government & Research Institutions : Japanese academic centers and government agencies need market data to inform funding decisions, research priorities, and policy development for genomic medicine advancement and healthcare innovation initiatives.

      Key Companies in the Japan Genomics Market

      CompanyHQOwnershipStrongest segments
      ABCAM PLCUnited KingdomPrivate CompanyReagents (antibodies, proteins, peptides, biochemicals),Kits (conjugation, cellular activity, pathway tools, immunoassays),Instruments and tools-adjacent products,
      AFFYMETRIX INCUnited StatesPrivate CompanyReagents,Kits,Instruments,
      BECKMAN COULTERUnited StatesPrivate CompanyInstruments (flow cytometers, centrifuges, capillary electrophoresis, liquid handlers, analyzers),Reagents & Kits (sample prep, library construction, single-cell PCR, immunoassay),Genome Profiling & Genomic Services,
      CEPHEID INC.United StatesPrivate CompanyInstruments (GeneXpert, SmartCycler),Reagents & Kits (Xpert tests and related consumables),Services (Genome profiling, bioinformatics, support),
      CORNING, INC.United StatesPublic CompanyReagents and Kits,Instruments and Lab Equipment,Labware and Specialty Surfaces for Genomics,
      DECODE GENETICSIcelandPrivate CompanyReagents,Kits,Instruments,
      GENOMIC HEALTH INCUnited StatesPrivate CompanyGenomic-based diagnostic services (oncology),Genome profiling services beyond core oncology,Bioinformatics and data-related services,
      UNILABSSwitzerlandPrivate CompanyReagents,Kits,Instruments,
      MAXCYTE, INCUnited StatesPublic CompanyInstruments (ExPERT ATx, STx, GTx, VLx),Consumables (Processing Assemblies, buffers, accessories),Licensing and technology access,
      DANAHER CORPORATIONUnited StatesPublic CompanyReagents and Kits,Instruments (Sequencing-adjacent, PCR, Flow Cytometry, Sample Prep),Services (Genome Profiling, Bioinformatics, Custom Development),
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyInstruments (sequencing-adjacent, PCR, flow cytometry, ISH platforms),Reagents and Kits,Genomics Services (Genome Profiling, CDMO, and Lab Services),
      REVVITYUnited StatesPublic CompanyReagents & Kits,Instruments,Genome Profiling Services,
      LABORATORY CORPORATION OF AMERICA HOLDINGSUnited StatesPublic CompanyReagents,Kits,Instruments,
      IQVIA INC.United StatesPublic CompanyGenomics Services – Genome Profiling & Central Labs,Bioinformatics & Real-World Genomics Analytics,Genomics-Enabled Clinical Research Services,
      CHARLES RIVER LABORATORIESUnited StatesPublic CompanyReagents,Kits,Instruments,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyReagents,Kits,Instruments,
      EUROFINS SCIENTIFICLuxembourgPublic CompanyReagents,Kits,Instruments,
      PACBIOUnited StatesPublic CompanyInstruments (Revio, Sequel, Vega, Onso),Reagents & Kits (SMRT cells, prep, binding, sequencing kits),Services (Genome profiling, bioinformatics and related),
      OXFORD NANOPORE TECHNOLOGIES PLC.United KingdomPublic CompanyInstruments (MinION, GridION, PromethION family),Reagents & Kits,Genome Profiling & Sequencing Services,
      TAKARA BIO INC.JapanPrivate CompanyReagents,Kits,Instruments,

      ABCAM PLC

      Abcam PLC is a United Kingdom-based private company founded in 1998 with 1,760 employees that develops and supplies research reagents and tools for the life sciences industry.

      AFFYMETRIX INC

      Affymetrix Inc. is a United States-based private company founded in 1991 with 1,150 employees focused on molecular biology and genomic analysis technologies.

      BECKMAN COULTER

      Beckman Coulter is a United States-based private company founded in 1935 with 11,900 employees that manufactures and distributes laboratory instruments and diagnostic equipment.

      CEPHEID INC.

      Cepheid Inc. is a United States-based private company founded in 1996 with 1,700 employees that develops molecular diagnostic systems and point-of-care testing solutions.

      CORNING, INC.

      Corning, Inc. is a United States-based public company founded in 1851 with 67,200 employees that manufactures specialty glass, ceramics, and laboratory equipment.

      DECODE GENETICS

      deCODE Genetics is an Iceland-based private company founded in 1996 with 331 employees focused on genomic research and genetic analysis.

      GENOMIC HEALTH INC

      Genomic Health Inc. is a United States-based private company founded in 2000 with 829 employees specializing in genomic-based diagnostic testing.

      UNILABS

      Unilabs is a Switzerland-based private company founded in 1987 with 1,897 employees providing clinical laboratory and diagnostic testing services.

      MAXCYTE, INC

      MaxCyte, Inc. is a United States-based public company founded in 1998 with 91 employees developing cell engineering and electroporation technologies.

      DANAHER CORPORATION

      Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees operating a diversified portfolio of businesses including life sciences and diagnostics.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees manufacturing analytical instruments and life sciences equipment.

      REVVITY

      Revvity is a United States-based public company founded in 1937 with 11,000 employees providing analytical instruments and life sciences solutions.

      LABORATORY CORPORATION OF AMERICA HOLDINGS

      Laboratory Corporation of America Holdings is a United States-based public company founded in 1995 with 66,385 employees operating one of the largest clinical laboratory networks.

      IQVIA INC.

      IQVIA Inc. is a United States-based public company with 93,000 employees providing clinical research, data analytics, and technology solutions to the pharmaceutical and healthcare industries.

      CHARLES RIVER LABORATORIES

      Charles River Laboratories is a United States-based public company founded in 1947 with 19,000 employees providing preclinical and clinical laboratory services for drug development.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees manufacturing and distributing life science research and clinical diagnostic products.

      EUROFINS SCIENTIFIC

      Eurofins Scientific is a Luxembourg-based public company founded in 1987 with 65,694 employees providing laboratory testing and analytical services across multiple industries.

      PACBIO

      PacBio is a United States-based public company founded in 2000 with 485 employees developing long-read DNA sequencing technologies.

      OXFORD NANOPORE TECHNOLOGIES PLC.

      Oxford Nanopore Technologies PLC. is a United Kingdom-based public company founded in 2005 with 1,316 employees specializing in nanopore-based DNA and RNA sequencing technologies.

      TAKARA BIO INC.

      Takara Bio Inc. is a Japan-based private company founded in 2002 with 1,779 employees providing molecular biology reagents and biotechnology products.

      Reasons to Buy this Report

      • Japan-Specific Market Sizing : Obtain precise market valuations and forecasts tailored to Japan's genomics sector, enabling accurate budgeting and investment decisions for market entry or expansion strategies in this high-value Asian market.
      • Competitive Landscape Intelligence : Understand Japan's unique competitive dynamics, key players, and market consolidation trends specific to microarray technology adoption in clinical and research settings across the country.
      • Regulatory & Reimbursement Insights : Gain detailed knowledge of Japan's healthcare regulations, reimbursement policies, and clinical integration pathways that directly impact genomic technology adoption and market growth trajectories.
      • Demographic-Driven Opportunity Analysis : Leverage insights on Japan's aging population and associated healthcare needs to identify high-growth segments in disease diagnosis, preventive genomics, and personalized treatment applications.
      • Strategic Partnership & Investment Guidance : Access actionable intelligence on collaboration opportunities, acquisition targets, and investment priorities within Japan's genomics ecosystem to maximize market penetration and revenue growth.

      Frequently asked questions

      What is the market size of Microarrays in 2025?

      Microarrays market is estimated at USD 1,756.4 million in 2025.

      What is the projected market size of Microarrays by 2030?

      Microarrays market is forecast to reach USD 2,568.0 million by 2030.

      What is the CAGR for Microarrays from 2025 to 2030?

      Microarrays market is expected to grow at a compound annual growth rate of 7.9%.

      What are the primary applications of Microarrays in genomics?

      Microarrays are used for disease diagnosis, pharmacogenomics, copy number variation detection, and large-scale research applications requiring simultaneous analysis of thousands of genetic markers.

      How do Microarrays compare to next-generation sequencing?

      Microarrays offer faster turnaround times and lower per-sample costs for targeted analysis, while next-generation sequencing provides greater flexibility and discovery potential for novel variants.

      RESEARCH METHODOLOGY

      This research study utilized extensive secondary sources, directories, and databases to identify and collect valuable information for analyzing the global genomics market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to gather and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Secondary Research

      Secondary research was primarily used to identify and collect information for the comprehensive, technical, market-oriented, and commercial study of the genomics market. The secondary sources used for this study include Nucleic Acids Research, Genome Biology, the International Journal of Genomics, the National Human Genome Research Institute (NHGRI), the International Chromosome and Genome Society (ICGS), Genome Canada, the European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, the Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), Nature Reviews Genetics, Nature Methods, the Biotechnology and Biological Sciences Research Council (BBSRC), the Organisation for Economic Co-operation and Development (OECD), Genome Research, the National Cancer Institute (NCI), the European Medicines Agency (EMA), the Population Health Research Institute (PHRI), PubMed, World Bank, the World Health Organization (WHO), Eurostat, and Factiva; research journals; corporate filings, such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also utilized to gather key information about major players, market classification, and segmentation, as well as industry trends, regional/country-level markets, market developments, and technological perspectives.

      Primary Research

      After acquiring foundational knowledge about the global genomics market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from academic & research institutes, hospitals, clinics & diagnostic labs, pharmaceutical & biopharmaceutical industries, CROs, and other end users. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.

      These interviews spanned six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while the remaining 30% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.

      The following is a breakdown of the primary respondents:

      Genomics Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the genomics market. These methods were also used extensively to estimate the size of various market segments. The research methodology used to estimate the market size includes the following:

      After determining the overall market size through the estimation process, the total market was divided into several segments and subsegments.

      Genomics Market : Top-Down and Bottom-Up Approach

      Genomics Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Genomics is a branch of molecular biology that involves the study of the structure, function, evolution, and mapping of genomes. It applies the techniques of genetics, molecular biology, and bioinformatics to sequence, assemble, and analyze the function and structure of the genome of a selected organism for analysis. Genomics is widely used in diagnostics, drug discovery and development, animal and agricultural research, forensics, and aquaculture research, among others.

      Key Stakeholders

      • Genomics Equipment and Consumable Manufacturing Companies
      • Genomics Instrument/System Manufacturing Companies
      • Suppliers and Distributors of Genomic Instruments/Systems, Consumables, and Services
      • Hospitals, Diagnostic Centers, and Medical Colleges
      • Research Institutes
      • Hospitals and Academic Medical Centers (AMCs)
      • Government Bodies/Municipal Corporations
      • Business Research Firms
      • Venture Capitalists
      • Pharmaceutical and Biopharmaceutical Companies

      Report Objectives

      • To define, describe, and forecast the genomics market based on offering, product type, service type, product by technology, application, end user by product, end user by service, and region, in terms of value
      • To forecast the size of the market segments with respect to six main regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, in terms of value
      • To provide detailed information regarding the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall genomics market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To profile key players in the genomics market and comprehensively analyze their product and service portfolios, market positions, and core competencies
      • To track and analyze competitive developments in the genomics market, such as acquisitions, product & service launches, expansions, agreements, partnerships, and collaborations
      • To benchmark players within the genomics market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for this report:

      Portfolio Assessment

      • Product Matrix, which gives a detailed comparison of the product & service portfolios of the top three companies.

      Company Information

      • Detailed analysis and profiling of additional market players (up to three).

      Geographical Analysis

      • A further breakdown of the Rest of Asia Pacific genomics market into countries
      • A further breakdown of the Rest of Europe genomics market into countries
      • A further breakdown of the Rest of Latin America genomics market into countries
      • A further breakdown of the Rest of Middle East genomics market into countries

       

      Get the Full Genomics Market Report

      Full forecast, segment splits, and company analysis for all Genomics Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status